
All g article
Was covered in Ag funder but cultivated x is a bit better on the research. Id say probably the right next IPO.

Was covered in Ag funder but cultivated x is a bit better on the research. Id say probably the right next IPO.
The deadline was supposed to be July 20, but it’s been extended bc there were apparently multiple companies showing interest. It’s unfortunately not known which companies other than Upside were interested, but it’s rather unlikely any of them are ANIC bc I don’t think any of them have more than $50m lying around (please correct me if I’m wrong). The factory is a big deal bc its capacity is 100x the current global CM output. I just hope it’ll actually be used for CM and not be converted to a data center or smth
Just got an auto update on Liberation Bioindustries:
A new operational signal appeared on 22 July 2026: Liberation Bioindustries posted an Operations Manager role for its Richmond facility.
The listing says:
The manager is expected to start in Q3 or Q4 2026, depending on construction progress.
The Richmond plant remains under construction.
Liberation now anticipates facility start-up in late 2026 or early 2027.
The role will oversee day-to-day manufacturing, maintenance and logistics and requires the manager to relocate before start-up.
This suggests Liberation is still preparing for commissioning rather than abandoning the site. However, it is not confirmation that completion financing has been secured or construction has restarted. The “late 2026 or early 2027” wording also indicates the operating timeline remains uncertain.
There has been no newer Agronomics regulatory announcement since 14 July 2026.
Source:
https://salutemyjob.com/jobs/operations-manager-richmond-indiana/2887681547-2/
One of the biggest players in the meat industry, Archer Daniels Midland (ADM), announced that it will begin mass-manufacturing egg whites via precision fermentation using the EVERY Company's OvoPro: https://www.fooddive.com/news/adm-every-ovopro-eggs-precision-fermentation-protein-ingredients/825437/
Agronomics Limited (AIM: ANIC), a leading listed company focused on the field of clean food, announces that it was notified on 13 July 2026 that Jim Mellon, Executive Chair of the Company, purchased 27,490,407 ordinary shares of £0.000001 each in the Company ("Ordinary Shares") for total consideration of US$2,000,000 (approximately £1,493,200) at a price of 5.43 pence per Ordinary Share on 13 July 2026. The Ordinary Shares were purchased from BlueNalu, Inc. ("BlueNalu").
The Company announced on 30 December 2025 that BlueNalu had been issued 30,643,003 Ordinary Shares as part of a funding round for BlueNalu. BlueNalu had notified the Company's broker of its intention to sell those Ordinary Shares, subject to the applicable lock-in and orderly market arrangements. Mr Mellon's acquisition avoids those Ordinary Shares being sold in the market and provides immediate working capital to BlueNalu.
Mr Mellon has also been granted a right of first refusal to acquire the remaining 3,152,596 Ordinary Shares held by BlueNalu at a price to be agreed by the parties at the time the right of first refusal is exercised. The right of first refusal expires on 1 October 2026.
To facilitate the acquisition by Mr Mellon, the Company has waived the lock-in and orderly market restrictions imposed on BlueNalu at the time the Ordinary Shares were issued (the "Waiver"). As a condition of Mr Mellon's acquisition, he has agreed to equivalent lock-in and orderly market arrangements with the Company in relation to the Ordinary Shares acquired from BlueNalu. Mr Mellon has confirmed to the Board that he has no current intention to sell any Ordinary Shares. He has also purchased Ordinary Shares in the market during 2026 and has indicated that it remains his intention to continue purchasing additional Ordinary Shares should the current significant discount to the Company's published net asset value continue.
As at close of business on 10 July 2026, the Ordinary Shares traded at a discount of approximately 56 per cent. to the Company's net asset value per share as at 30 June 2026 of 12.93 pence, as published on 10 July 2026.
As a further condition of the Waiver, BlueNalu has agreed that the Company shall be granted the right to appoint a director nominee to the board of BlueNalu; previously, the Company had the right to appoint an observer only. Following completion of Mr Mellon's acquisition, Mr Mellon has been appointed as a director of BlueNalu as the Company's appointed nominee.
Following the investment announced on 30 December 2025, Agronomics holds 2,519,609 preferred shares of BlueNalu with a book value, inclusive of the CPN investment at face value, of approximately US$ 15.54 million. Following the share subscription and the consummation of BlueNalu's convertible promissory note round, Agronomics is expected to hold approximately 12.96 per cent. of BlueNalu's issued shares on a fully diluted basis.
In addition to the acquisition from BlueNalu, brokers acting for Mr Mellon acquired a further 6,050,000 Ordinary Shares between 13 March 2026 and 27 March 2026. These purchases were not previously notified by the Company and are set out below: (see link for the table)
Following the acquisitions described above, Mr Mellon's total interest in the Company, including interests held by persons closely associated with him, is 199,316,404 Ordinary Shares, representing 18.30 per cent. of the Company's total voting rights held as follows: Jim Mellon directly: 41,347,369, Galloway Limited: 157,944,938 and Shellbay Investments Limited: 24,097.
I’ve been following this stock since 2020, this has helped me correctly call some significant movements and conversely, avoid the… Extensive down swing. Over time I’ve built up a thesis on what exactly moves the stock and what doesn’t. I’ve illustrated this in the chart above.
The first parabolic run (almost 1000%) was courtesy of a golden combination of low interest rates, hype in alternate proteins and Jim Mellon publishing the book ‘Moo’s Law’ and going on interview circuits, putting Agronomics and lab grown meat in worldwide news.
Unfortunately due to the market crash, interest rate hikes, funding conditions, company attrition and, ultimately, the difficulty and time it has taken to actually pull off this science fiction technology. The stock slowly drifted back down over the last 4 years.
The second smaller wave was triggered by Agronomics once again hitting worldwide news due to a company within its portfolio (Meatly) successfully being the first company in the world to ‘bring lab grown meat to the shelves.’ This resulted in a smaller (about 130%) run.
Despite the impressive display of technology this was in the end, just dog food and so the stock has drifted down somewhat. Which leads us to what I believe will trigger the next parabolic run.
In Spring 2027 Lab Grown Meat will be legal to sell to humans in the UK two companies within the Agronomics portfolio are already part of this UK government sandbox fast track, Blue Nalu and Mosa Meat of which Agronomics owns 12.96% and 1.7% respectively. Agronomics also owns 27.8% of Supermeat and 11.57% of Meatly who are expected to immediately benefit from the legalisation, both attempting to finish factories in time.
This is going to be a worldwide news event, that is guaranteed, Agronomics remains the only way for a normal investor to invest in lab grown meat, multiple of their companies are directly involved and stand to significantly benefit. Every time there has been a worldwide news event with lab grown meat, Agronomics has gone on a run.
This is of course still a very risky bet on a new industry with considerable growing pains, only invest what you are willing to lose.
tldr: Agronomics (£ANIC) is a publicly listed investment fund of 20 companies using technology to revolutionise the food industry. Like the S&P500 for the future of food or being able to invest in solar panels or electric cars 15 years ago.
edit: op position; 1 million shares at 4p, proof in pinned post
Conversation with Steven Finn; he also mentions Liberation Bioindustries.
Steven Finn is a member of the board of Lib-Bio.
Obviously a terrible thing per se, but I can’t help but feel that it will accelerate the rise of precisions fermentation. Shortages of palm oil can only help CFGs business model.